AAAAAA

   
Results: 1-12 |
Results: 12
Frequent hypermethylation of the 5 ' CpG island of E-cadherin in esophageal adenocarcinoma
Authors: Corn, PG Heath, EI Heitmiller, R Fogt, F Forastiere, AA Herman, JG Wu, TT
Citation: Pg. Corn et al., Frequent hypermethylation of the 5 ' CpG island of E-cadherin in esophageal adenocarcinoma, CLIN CANC R, 7(9), 2001, pp. 2765-2769
Comment on The role of laparoscopy in preoperative staging of esophageal cancer - Reply
Authors: Heath, EI
Citation: Ei. Heath, Comment on The role of laparoscopy in preoperative staging of esophageal cancer - Reply, SURG ENDOSC, 15(5), 2001, pp. 529-529
Phase I trial of the matrix metalloproteinase inhibitor BAY12-9566 in patients with advanced solid tumors
Authors: Heath, EI O'Reilly, S Humphrey, R Sundaresan, P Donehower, RC Sartorius, S Kennedy, MJ Armstrong, DK Carducci, MA Sorensen, JM Kumor, K Kennedy, S Grochow, LB
Citation: Ei. Heath et al., Phase I trial of the matrix metalloproteinase inhibitor BAY12-9566 in patients with advanced solid tumors, CANC CHEMOT, 48(4), 2001, pp. 269-274
The role of laparoscopy in preoperative staging of esophageal cancer
Authors: Heath, EI Kaufman, HS Talamini, MA Wu, TT Wheeler, J Heitmiller, RF Kleinberg, L Yang, SC Olukayode, K Forastiere, AA
Citation: Ei. Heath et al., The role of laparoscopy in preoperative staging of esophageal cancer, SURG ENDOSC, 14(5), 2000, pp. 495-499
Mutations in beta-catenin and APC genes are uncommon in esophageal and esophagogastric junction adenocarcinomas
Authors: Choi, YW Heath, EI Heitmiller, R Forastiere, AA Wu, TT
Citation: Yw. Choi et al., Mutations in beta-catenin and APC genes are uncommon in esophageal and esophagogastric junction adenocarcinomas, MOD PATHOL, 13(10), 2000, pp. 1055-1059
Adenocarcinoma of the esophagus: Risk factors and prevention (vol 14, pg 512, 2000)
Authors: Heath, EI Limburg, PJ Hawk, ET Forastiere, AA
Citation: Ei. Heath et al., Adenocarcinoma of the esophagus: Risk factors and prevention (vol 14, pg 512, 2000), ONCOLOGY-NY, 14(7), 2000, pp. 963-963
Adenocarcinoma of the esophagus: Risk factors and prevention
Authors: Heath, EI Limburg, PJ Hawk, ET Forastiere, AA
Citation: Ei. Heath et al., Adenocarcinoma of the esophagus: Risk factors and prevention, ONCOLOGY-NY, 14(4), 2000, pp. 507-514
Phase II evaluation of preoperative chemoradiation and postoperative adjuvant chemotherapy for squamous cell and adenocarcinoma of the esophagus
Authors: Heath, EI Burtness, BA Heitmiller, RF Salem, R Kleinberg, L Knisely, JPS Yang, SC Talamini, MA Kaufman, HS Canto, MI Topazian, M Wu, TT Olukayode, K Forastiere, AA
Citation: Ei. Heath et al., Phase II evaluation of preoperative chemoradiation and postoperative adjuvant chemotherapy for squamous cell and adenocarcinoma of the esophagus, J CL ONCOL, 18(4), 2000, pp. 868-876
Clinical potential of matrix metalloprotease inhibitors in cancer therapy
Authors: Heath, EI Grochow, LB
Citation: Ei. Heath et Lb. Grochow, Clinical potential of matrix metalloprotease inhibitors in cancer therapy, DRUGS, 59(5), 2000, pp. 1043-1055
Therapy for esophageal cancer
Authors: Heath, EI Forastiere, AA
Citation: Ei. Heath et Aa. Forastiere, Therapy for esophageal cancer, CANC TREAT, 2000, pp. 387-398
Prognostic value of p53, glutathione S-transferase pi, and thymidylate synthase for neoadjuvant cisplatin-based chemotherapy in head and neck cancer
Authors: Shiga, H Heath, EI Rasmussen, AA Trock, B Johnston, PG Forastiere, AA Langmacher, M Baylor, A Lee, M Cullen, KJ
Citation: H. Shiga et al., Prognostic value of p53, glutathione S-transferase pi, and thymidylate synthase for neoadjuvant cisplatin-based chemotherapy in head and neck cancer, CLIN CANC R, 5(12), 1999, pp. 4097-4104
Gastroesophageal reflux and adenocarcinoma of the esophagus
Authors: Heath, EI Holbrook, JT Forastiere, AA
Citation: Ei. Heath et al., Gastroesophageal reflux and adenocarcinoma of the esophagus, N ENG J MED, 341(7), 1999, pp. 536-537
Risultati: 1-12 |